Headlines

Does Metformin Have Anti-Cancer Properties?

There have been conflicting findings on the diabetes drug metformin’s possible relationship to cancer.  The majority of studies conducted on metformin or other glucose-lowering medications and their effect on cancer risk have found inconclusive results, but some research suggests metformin may have a beneficial role in certain types of cancer. Read more

Gender Dysphoria and Type 1 Diabetes Linked

The rate of type 1 diabetes among transgender and gender-nonconforming young people is more than nine times higher than that of the general population, with researchers exploring the role of increased psychological stress among adolescents with both diagnoses, according to findings published in Pediatric Diabetes. Read more

Maternal Health And Childhood Obesity

Childhood obesity is a has many causes, and some evidence suggests possible exposure to in utero maternal obesity or gestational diabetes mellitus (GDM) might have a role. Read more

The Psychological Impact of Diabetes

The physical damage to the body caused by diabetes, and concern about growing rates of diabetes in children and teens, are widely discussed. But there are also some serious psychological effects to consider, and whether these are addressed might make the difference in whether someone is successful in managing their diabetes or not. Read more

Breast Cancer Drug May Help Type 1 Diabetes

A drug used to treat breast cancer, neratinib, has the potential to stop the immune system from destroying beta cells in type 1 diabetes, according to German researchers. The researchers found that Neratinib was able to protect the beta cells, which produce insulin in the pancreas, enabling the beta cells to continue to produce insulin. […]

Freestyle Libre Can Help People with Diabetes & Dementia

The FreeStyle Libre wearable monitor could be of great benefit in helping older people with diabetes and memory loss manage their condition better, according to researchers have said. The device automatically reads glucose levels without a fingerstick, making diabetes easier to manage. Read more

Sleep Especially Crucial for Teens with Type 1

Most adolescents get insufficient sleep that equates to less than the recommended 8 hours. Due to this, most teens with diabetes have poor adherence to their sleep schedule, thus worsening their chances of developing comorbid conditions. Read more

Canagliflozin Not a Fracture Risk After All?

In recent years, there have been warnings for the use of SGLT-2 Inhibitors that suggest an increased risk of fracture, particularly when placed on one SGLT2 inhibitor, canagliflozin (Invokana). In 2015, the US FDA added a warning on canagliflozin, indicating that patients on canagliflozin must use caution because of a fracture risk associated with the […]

Childhood Pancreatitis May Increase Chances for Type 2

Children who have had an episode of acute pancreatitis may have an increased risk for developing type 2 diabetes before the age of 40, researchers say. Read more

The Flu Increases Hospitalization Risk for Type 2 Patients

Serious influenza complications can result in a higher risk of hospitalization, and also mortality, in patients with diabetes. The influenza virus, commonly known as the flu, has the potential of exacerbating chronic health problems that lead to worsening the disease state of diabetes. Read more

New Trial for Combination Therapy

The TTT-1 trial will begin in Scotland early in 2020 to assess a new combination therapy using insulin, dapagliflozin, and semaglutide. It is being led by Dr John Petrie from the University of Glasgow, a leading expert in the treatment of type 1 diabetes. The trial hopes the treatment will become a new option for […]

Circadian Clocks Disrupted by Glucose, Obesity

The circadian clocks inside the body’s cells that help regulate timing of many body functions and control cardiovascular disease risks within a 24-hour day appear to be affected by high glucose in obesity. “We know that high glucose impairs circadian clock functions, but now we want to know [if] by fixing the clock can we […]

U.N. Seeks to Address Rising Insulin Costs

The World Health Organization (WHO) has announced a plan to lower the “overly expensive” price of insulin. The agency, which is part of the United Nations, wants other drug companies to produce generic versions of insulin, which it will then test. Since its discovery in 1923, the price of insulin has risen in the United […]

New Once-Daily Diabetes Pill

Qternmet XR is a single, once daily oral tablet made of dapagliflozin, saxagliptin, and metformin. Results show that the combination of dapagliflozin and saxagliptin have improved glycemic outcomes when added to metformin in patients with diabetes as compared to either drug alone added to metformin. Adverse effects are similar to those of the individual medications. […]

“Super-Grafts” to Treat Severe type 1

To save patients with a severe form of type 1 diabetes, pancreatic cell transplantation is a “last resort” treatment, because the process is long and complex, and many of the grafted cells die quickly. Researchers have found that adding amniotic epithelial cells to these cell clusters creates much more robust “super-islets” of Langerhans. Once transplanted, […]

Is There a “Best” Time of Day to Exercise?

When you have diabetes, whether there is a “best” time of day to exercise can depend on many things — whether you’re trying to lose weight or manage glucose; whether or not you take insulin; what kind of physical activity you’re doing, and many more. Diabetes exercise expert Dr. Sheri Colberg gives her insight into […]

The Complex Relationship Between Type 2 and Alzheimer’s

Researchers may be only beginning to understand how Alzheimer’s disease and type 2 diabetes could be linked. Deciphering the connection could lead to earlier Alzheimer’s diagnosis and better treatments for both diseases. The connection involves how the brain metabolizes blood sugar and the factors that influence that process, including diet, sleep, and cardiovascular health.   […]

First Oral GLP-1 For Type 2 Diabetes: Rybelsus

Oral semaglutide, brand name Rybelsus, is the first GLP-1 agonist that can be taken by mouth rather than requiring an injection. Studies have shown a significant reduction in A1c, a reduction in cardiovascular disease, and a reduction in weight, without the risk of hypoglycemia, for this drug. Patients must carefully follow instructions for taking the […]

“Automatic Insulin” Tech for Better Type 1 Management

A new study looked at a particular type of artificial pancreas, or closed-loop control, called the Control-IQ system — a new type of artificial pancreas that uses algorithms to adjust insulin doses automatically throughout the day. When the monitor detects that a person needs insulin, a pump releases it into the body. Read more

FDA Approval of Invokana for Kidney Disease “First Major Breakthrough in 20 Years”

The FDA has approved a new treatment of Invokana for diabetic chronic kidney disease (CKD), which affects one in three patients with type 2 diabetes. CKD increases the risk for serious cardiovascular events and end-stage renal disease in patiens with type 2 diabetes. The approval of Invokana meets a 20 year need for therapy to […]



Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner

Alltop

  • No items.